Longitudinal Monitoring of Plasma Circulating Tumour DNA Enables the Prediction of Early Relapse in Patients with Non-Hodgkin Lymphoma: A Case Series

Growing evidence now suggests that circulating tumour DNA (ctDNA) has great potential as a non-invasive biomarker for disease monitoring, since ctDNA carries tumour-specific modifications. In particular, monitoring ctDNA has important implications for identifying patients with haematological maligna...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Hongyan, Long, Xiaolu, Gu, Jia, Jin, Jin, Mao, Xia, Wang, Zhiqiong, Ma, Heng, Chen, Liting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618087/
https://www.ncbi.nlm.nih.gov/pubmed/34829401
http://dx.doi.org/10.3390/diagnostics11112055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618087/
https://www.ncbi.nlm.nih.gov/pubmed/34829401
http://dx.doi.org/10.3390/diagnostics11112055

Ejemplares similares